Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD

References

• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• FischerBMPavliskoEVoynowJAPathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammationInt J Chron Obstruct Pulmon Dis2011641321857781
   PubMed Web of Science ®Google Scholar
• BarnesPJChronic obstructive pulmonary disease: effects beyond the lungsPLoS Med201073e100022020305715
   PubMed Web of Science ®Google Scholar
• SinDDManSFWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation2003107111514151912654609
   PubMed Web of Science ®Google Scholar
• VagulieneNZemaitisMLavinskieneSMiliauskasSSakalauskasRLocal and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary diseaseBMC Immunol2013143623919722
   PubMed Web of Science ®Google Scholar
• YasudaNGotohKMinatoguchiSAn increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPDRespir Med19989289939999893764
   PubMed Web of Science ®Google Scholar
• AllwoodBWGillespieRGalperin-AizenbergMMechanism of airflow obstruction in tuberculosis-associated obstructive pulmonary disease (TOPD). D39. Connecting the dots: drawing lines between COPD and comorbid conditions: Proceeding of ATS Conferences, San Diego, CA, 21 May 2014Am Thorac Soc2014189A5832
   Google Scholar
• SarkarMSrinivasaMadabhaviIKumarKTuberculosis associated chronic obstructive pulmonary diseaseClin Respir J201711328529528268242
   PubMed Web of Science ®Google Scholar
• PasipanodyaJGMillerTLVecinoMPulmonary impairment after tuberculosisChest200713161817182417400690
   PubMed Web of Science ®Google Scholar
• RyuYJLeeJHChunEMChangJHShimSSClinical outcomes and prognostic factors in patients with tuberculous destroyed lungInt J Tuberc Lung Dis201115224625021219689
   PubMed Web of Science ®Google Scholar
• YakarHIGunenHPehlivanEAydoganSThe role of tuberculosis in COPDInt J Chron Obstruct Pulmon Dis20171232332928176901
   PubMed Web of Science ®Google Scholar
• KimCJYoonHKParkMJInhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY studyInt J Chron Obstruct Pulmon Dis201712158928615931
   PubMed Web of Science ®Google Scholar
• TangSCuiHYaoLIncreased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary diseasePLoS One201384e6238523626814
   PubMed Web of Science ®Google Scholar
• de La MoraILMartínez-OcegueraDLaniado-LaborínRChronic airway obstruction after successful treatment of tuberculosis and its impact on quality of lifeInt J Tuberc Lung Dis201519780881026056106
   PubMed Web of Science ®Google Scholar
• HwangYIKimJHLeeCYThe association between airflow obstruction and radiologic change by tuberculosisJ Thorac Dis20146547147624822105
   PubMed Web of Science ®Google Scholar
• MalherbeSTShenaiSRonacherKPersisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureNat Med201622101094110027595324
   PubMed Web of Science ®Google Scholar
• Ugarte-GilCAElkingtonPGilmanRHInduced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosisPLoS One201384e6133323613834
   PubMed Web of Science ®Google Scholar
• RadovicMRisticLCiricZChanges in respiratory function impairment following the treatment of severe pulmonary tuberculosis – limitations for the underlying COPD detectionInt J Chron Obstruct Pulmon Dis2016111307131627366058
   PubMed Web of Science ®Google Scholar
• ByrneALMaraisBJMitnickCDLeccaLMarksGBTuberculosis and chronic respiratory disease: a systematic reviewInt J Infect Dis20153213814625809770
   PubMed Web of Science ®Google Scholar
• JordanTSSpencerEMDaviesPTuberculosis, bronchiectasis and chronic airflow obstructionRespirology201015462362820409028
   PubMed Web of Science ®Google Scholar
• GatheralTKumarNSansomBCOPD-related bronchiectasis; independent impact on disease course and outcomesCOPD201411660561424983298
   PubMedGoogle Scholar
• MaoBLuHWLiMHThe existence of bronchiectasis predicts worse prognosis in patients with COPDSci Rep201551096126077673
   PubMed Web of Science ®Google Scholar
• GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
   PubMed Web of Science ®Google Scholar
• ConnorsAFJrDawsonNVThomasCOutcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)Am J Respir Crit Care Med19961549599678887592
   PubMed Web of Science ®Google Scholar
• WedzichaJADonaldsonGCExacerbations of chronic obstructive pulmonary diseaseResp Care20034812041213
   PubMedGoogle Scholar
• Garcia-AymerichJMonsóEMarradesRMRisk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM studyAm J Respir Crit Care Med200116461002100711587986
   PubMed Web of Science ®Google Scholar
• KerkhofMFreemanDJonesRPredicting frequent COPD exacerbations using primary care dataInt J Chron Obstruct Pulmon Dis2015102439245026609229
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
   PubMed Web of Science ®Google Scholar
• RavimohanSKornfeldHWeissmanDBissonGPTuberculosis and lung damage: from epidemiology to pathophysiologyEur Respir Rev20182714717007729491034
   PubMed Web of Science ®Google Scholar
• ManjiMShayoGMamuyaSMpembeniRJusabaniAMugusiFLung functions among patients with pulmonary tuberculosis in Dar es Salaam – a cross-sectional studyBMC Pulm Med20161615827107713
   PubMed Web of Science ®Google Scholar
• RheeCKYooKHLeeJHClinical characteristics of patients with tuberculosis-destroyed lungInt J Tuberc Lung Dis2013171677523232006
   PubMed Web of Science ®Google Scholar
• SantraADuttaPManjhiRPothalSClinico-radiologic and spirometric profile of an Indian population with post-tuberculous obstructive airway diseaseJ Clin Diagn Res2017113OC35OC3828511433
   PubMedGoogle Scholar
• ChungKFCytokines in chronic obstructive pulmonary diseaseEur Respir J Suppl200134S50S59
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTAPatelISAirway and systemic inflammation and decline in lung function in patients with COPDChest200512841995200416236847
   PubMed Web of Science ®Google Scholar
• YendeSWatererGWTolleyEAInflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjectsThorax2006611101616284220
   PubMed Web of Science ®Google Scholar
• AgustíAEdwardsLDRennardSIPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One201275e3748322624038
   PubMed Web of Science ®Google Scholar